今天分享一本对国人友好、喜欢接收纯生信的3区期刊——Cancer Medicine，影响因子：3.491，审稿周期：3-6个月，版面费：$3,025，不在中科院《国际期刊预警名单（试行）》名单（ 2021年1月发布版）上，不用担心毕业或者评职称问题，主要优点就是：对国人友好、喜欢接收纯生信。
期刊收录范围就包含生信：
Clinical Cancer Research
Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations
Cancer Biology
Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery
Cancer Prevention
Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach
Bioinformatics
Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers
最新出版的生信文章：
1: Wang Z, Pan L, Guo D, Luo X, Tang J, Yang W, Zhang Y, Luo A, Gu Y, Pan Y. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma. Cancer Med. 2021 May 2. doi: 10.1002/cam4.3900. Epub ahead of print. PMID: 33934539.
2: Ren S, Wang W, Zhang C, Sun Y, Sun M, Wang Y, Zhang X, Lu B, Yao L. The low expression of NUP62CL indicates good prognosis and high level of immune infiltration in lung adenocarcinoma. Cancer Med. 2021 May 2. doi:10.1002/cam4.3877. Epub ahead of print. PMID: 33934535.
3: Zhou L, Li SH, Wu Y, Xin L. Establishment of a prognostic model of four genes in gastric cancer based on multiple data sets. Cancer Med. 2021 May 2. doi:10.1002/cam4.3654. Epub ahead of print. PMID: 33934516.